资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医迅达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
map
#抗肿瘤活性#
37篇内容 | 1456人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=5521556518b, topicName=抗肿瘤活性, introduction=抗肿瘤活性, content=null, image=null, comments=37, allHits=1456, url=https://h5.medsci.cn/topic?id=55651, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57554, tagList=[TagDto(tagId=57554, tagName=抗肿瘤活性)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2181601, encodeId=aa97218160122, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a> <a href='/topic/show?id=07fe10530819' target=_blank style='color:#2F92EE;'>#德曲妥珠单抗#</a>, objectTitle=肿瘤体积缩小,超60%患者客观缓解!乳腺癌创新疗法具有持久抗肿瘤活性, objectType=article, longId=809263, objectId=1b5b80926328, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=1b5b80926328, replyNumber=0, likeNumber=80, createdTime=2024-01-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=1b5b80926328, moduleTitle=肿瘤体积缩小,超60%患者客观缓解!乳腺癌创新疗法具有持久抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b5b80926328)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1674974, encodeId=304816e497420, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=中药及活性成分可以发挥抗肿瘤活性,抑制肝癌, objectType=article, longId=726474, objectId=a1f1e2647499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f1e2647499, replyNumber=0, likeNumber=87, createdTime=2023-04-16, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f1e2647499, moduleTitle=中药及活性成分可以发挥抗肿瘤活性,抑制肝癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a1f1e2647499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674973, encodeId=da8b16e497310, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Lancet Oncol:尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性, objectType=article, longId=295173, objectId=79422951e301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79422951e301, replyNumber=0, likeNumber=55, createdTime=2022-08-20, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79422951e301, moduleTitle=Lancet Oncol:尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79422951e301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674969, encodeId=ab9316e496974, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Clin Cancer Res:Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物, objectType=article, longId=214645, objectId=1284214645f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1284214645f5, replyNumber=0, likeNumber=53, createdTime=2022-01-05, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1284214645f5, moduleTitle=Clin Cancer Res:Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1284214645f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674971, encodeId=bad216e4971ae, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Clin Cancer Res:卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性, objectType=article, longId=216259, objectId=c9c62162592f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9c62162592f, replyNumber=0, likeNumber=59, createdTime=2021-11-24, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9c62162592f, moduleTitle=Clin Cancer Res:卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c9c62162592f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674968, encodeId=77cd16e49689a, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Lancet oncol:Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, objectType=article, longId=211377, objectId=f1712113e75f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1712113e75f, replyNumber=0, likeNumber=53, createdTime=2021-08-09, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1712113e75f, moduleTitle=Lancet oncol:Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1712113e75f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674970, encodeId=f47016e497017, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Lancet Oncol:PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性, objectType=article, longId=215592, objectId=aefb21559219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aefb21559219, replyNumber=0, likeNumber=66, createdTime=2022-05-25, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aefb21559219, moduleTitle=Lancet Oncol:PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aefb21559219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674972, encodeId=e4db16e497266, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Clin Cancer Res:PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, objectType=article, longId=220797, objectId=5c23220e97c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c23220e97c1, replyNumber=0, likeNumber=108, createdTime=2022-06-30, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c23220e97c1, moduleTitle=Clin Cancer Res:PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c23220e97c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674966, encodeId=65ac16e496605, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Nat Commun:地西他滨处理CAR-T细胞,能增强其抗肿瘤活性, objectType=article, longId=206197, objectId=a7aa20619ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7aa20619ebe, replyNumber=0, likeNumber=67, createdTime=2021-12-05, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7aa20619ebe, moduleTitle=Nat Commun:地西他滨处理CAR-T细胞,能增强其抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a7aa20619ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674967, encodeId=af5c16e49673e, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Clin Cancer Res:PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, objectType=article, longId=206884, objectId=a7cd206884c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7cd206884c6, replyNumber=0, likeNumber=70, createdTime=2021-02-12, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7cd206884c6, moduleTitle=Clin Cancer Res:PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a7cd206884c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674965, encodeId=6cf616e49654a, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, objectType=article, longId=205972, objectId=009f2059e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009f2059e2f7, replyNumber=0, likeNumber=66, createdTime=2021-12-01, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009f2059e2f7, moduleTitle=ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=009f2059e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674963, encodeId=fa0016e4963ae, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Lancet oncol:RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性, objectType=article, longId=202766, objectId=2fe5202e6622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe5202e6622, replyNumber=0, likeNumber=67, createdTime=2021-05-19, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe5202e6622, moduleTitle=Lancet oncol:RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2fe5202e6622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674964, encodeId=46f816e4964bc, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Blood:水杨酸盐可增强CRM1抑制剂的抗肿瘤活性, objectType=article, longId=203481, objectId=9f55203481b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f55203481b5, replyNumber=0, likeNumber=65, createdTime=2021-08-20, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f55203481b5, moduleTitle=Blood:水杨酸盐可增强CRM1抑制剂的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f55203481b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674962, encodeId=6bba16e496250, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性, objectType=article, longId=193094, objectId=3ff319309444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ff319309444, replyNumber=0, likeNumber=85, createdTime=2020-08-21, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ff319309444, moduleTitle=抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ff319309444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674959, encodeId=4ece16e4959ba, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Blood:Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性, objectType=article, longId=182245, objectId=ac0518224573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0518224573, replyNumber=0, likeNumber=68, createdTime=2020-02-06, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0518224573, moduleTitle=Blood:Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ac0518224573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674961, encodeId=8c1a16e49614a, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Nat Immuno: 找到免疫治疗好帮手了!科学家发现,抑制CD36可阻断调节T细胞对肿瘤微环境的适应,增强抗肿瘤活性, objectType=article, longId=191006, objectId=817819100609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817819100609, replyNumber=0, likeNumber=75, createdTime=2021-03-01, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817819100609, moduleTitle=Nat Immuno: 找到免疫治疗好帮手了!科学家发现,抑制CD36可阻断调节T细胞对肿瘤微环境的适应,增强抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=817819100609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674960, encodeId=d1ec16e4960bf, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Blood:hnCD16-iNK细胞的抗肿瘤活性, objectType=article, longId=185065, objectId=e4711850656f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4711850656f, replyNumber=0, likeNumber=71, createdTime=2020-05-26, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4711850656f, moduleTitle=Blood:hnCD16-iNK细胞的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e4711850656f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674957, encodeId=484b16e4957c0, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Lancet oncol:瑞戈非尼用于晚期骨肉瘤成人患者,具有明显的抗肿瘤活性,可延缓病程进展, objectType=article, longId=154390, objectId=6b3115439045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b3115439045, replyNumber=0, likeNumber=51, createdTime=2019-02-19, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b3115439045, moduleTitle=Lancet oncol:瑞戈非尼用于晚期骨肉瘤成人患者,具有明显的抗肿瘤活性,可延缓病程进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6b3115439045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674958, encodeId=198e16e4958f9, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=CLIN CANCER RES:靶向PCNA小分子的抗肿瘤活性, objectType=article, longId=156171, objectId=178b1561e1c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=178b1561e1c2, replyNumber=0, likeNumber=59, createdTime=2019-10-19, rootId=0, userName=cmj17wellington, userId=cf5227147934, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=178b1561e1c2, moduleTitle=CLIN CANCER RES:靶向PCNA小分子的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=178b1561e1c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674954, encodeId=d91816e4954c2, content=<a href='/topic/show?id=5521556518b' target=_blank style='color:#2F92EE;'>#抗肿瘤活性#</a>, objectTitle=Brit J Cancer:派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, objectType=article, longId=148662, objectId=655114866244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=655114866244, replyNumber=0, likeNumber=88, createdTime=2019-03-15, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=655114866244, moduleTitle=Brit J Cancer:派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=655114866244)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
抗肿瘤活性
2020-05-29
梅斯管理员
(审核中...)
关注
已关注
前往app查看评论内容
#乳腺癌#
#抗肿瘤活性#
#德曲妥珠单抗#
肿瘤体积缩小,超60%患者客观缓解!乳腺癌创新疗法具有持久抗肿瘤活性
80
0
2024-01-14发表于陕西省
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
中药及活性成分可以发挥抗肿瘤活性,抑制肝癌
87
0
2023-04-16
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Lancet Oncol:尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性
55
0
2022-08-20
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Clin Cancer Res:Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物
53
0
2022-01-05
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Clin Cancer Res:卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性
59
0
2021-11-24
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Lancet oncol:Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期
53
0
2021-08-09
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Lancet Oncol:PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性
66
0
2022-05-25
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Clin Cancer Res:PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性
108
0
2022-06-30
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Nat Commun:地西他滨处理CAR-T细胞,能增强其抗肿瘤活性
67
0
2021-12-05
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Clin Cancer Res:PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性
70
0
2021-02-12
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性
66
0
2021-12-01
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Lancet oncol:RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性
67
0
2021-05-19
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Blood:水杨酸盐可增强CRM1抑制剂的抗肿瘤活性
65
0
2021-08-20
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性
85
0
2020-08-21
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Blood:Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性
68
0
2020-02-06
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Nat Immuno: 找到免疫治疗好帮手了!科学家发现,抑制CD36可阻断调节T细胞对肿瘤微环境的适应,增强抗肿瘤活性
75
0
2021-03-01
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Blood:hnCD16-iNK细胞的抗肿瘤活性
71
0
2020-05-26
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Lancet oncol:瑞戈非尼用于晚期骨肉瘤成人患者,具有明显的抗肿瘤活性,可延缓病程进展
51
0
2019-02-19
回复
cmj17wellington
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
CLIN CANCER RES:靶向PCNA小分子的抗肿瘤活性
59
0
2019-10-19
回复
仁医06
(审核中...)
关注
已关注
前往app查看评论内容
#抗肿瘤活性#
Brit J Cancer:派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性
88
0
2019-03-15
回复
共38条
首页
上一页
下一页
尾页
页码:
1
/2页
20条/页
扫描二维码下载梅斯医学APP
map
科室
订阅+
更多科室
工具
服务
map
map